Engineered skin tissues must reproduce the biological and mechanical functions of their native counterparts if they are to provide health benefits to society. However, engineered skin substitute (ESS) only fulfills basic skin functions and fails to match the structural and biophysical characteristics of the human skin, such as missing hair follicle and sweat gland, limiting its use in vivo. Their absences are due to a lack of functioning cell types that instruct human keratinocytes in ESS to make a hair follicle and a lack of an in-depth understanding of essential epithelial-mesenchymal interactions that drive hair follicle formation. In the case of hair follicle engineering, the epithelial-mesenchymal interactions between keratinocytes and their immediate dermal environment need to be precisely modulated to govern hair follicle lineage commitment. The major cell type that constitutes a unique dermal ?niche? is a specialized population of fibroblasts, which are located at the base of the hair follicle, called the dermal papilla (DP), and are different from normal human dermal fibroblasts. However, it is of great difficulty to isolate and expand human DP fibroblasts in vitro while maintaining their inductive capacity for tissue engineering purposes. The long-term goal is to develop novel bioengineering approaches to produce a fully functional human skin equivalent with normal microanatomy. The central hypothesis is that hair follicle induction is an emergent property of skin constructs, which requires the interplay of multiple signals and cell types in an inductive microenvironment. The objectives are to systemically explore how to create an inductive microenvironment in ESS to induce hair follicle formation. To achieve this, we have devised a three-pronged strategy addressing hair follicle bioengineering in ESS: 1) mimic the original niche by fabricating composite keratinocyte-DP cell spheroids in micropatterned ESS; 2) enhance intercellular interactions by adding BMP6 and 3) drive the DP phenotype by re-activating master transcription factors. In the first aim, we will determine if multi- cell type spheroids combined with premade hair canals can mimic a natural niche in ESS. We have developed two 3D composite spheroid models and will determine whether they will allow DP fibroblasts to expand in vitro while maintaining DP inductivity to induce hair follicles in a laser micropatterned skin substitute model. In the second aim, we will determine the inductive functions of Bmp6 in stimulating hair follicle formation in ESS. We will dissect the roles of Bmp6 in hair follicle formation and growth. In the third aim, we will determine whether human DP fibroblasts can be reprogrammed to reestablish hair inductivity. We will assess whether in vitro genetic reprogramming of human DP fibroblasts by CRISPRa-mediated expression of master transcription factors promote the ability of composite keratinocyte-DP cell spheroids to induce hair follicles in ESS. This work will provide novel mechanistic knowledge of spatial niche arrangement, inductive signals, and genetic programs that is critical to promote hair follicle neogenesis in ESS. The outcomes are significant because it will accelerate hair follicle bioengineering and advance complex in vitro and in vivo tissue engineering and regenerative medicine.

Public Health Relevance

Engineered skin substitute (ESS) has been successfully used for wound closure in burns, burn scars, chronic wounds, and giant nevi. However, ESS only fulfills basic skin functions and fails to match the structural and biophysical characteristics of the human skin. The proposed research will apply a three-pronged strategy to bioengineer hair follicles in ESS: fabricating the hair follicle niche environment at the tissue level, stimulating with BMP6 at the molecular level, and reprogramming the DP phenotype at the genetic level The knowledge gained is of great importance to engineer fully functional skin constructs and promote regenerative medicine.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Project (R01)
Project #
1R01AR077238-01A1
Application #
10121770
Study Section
Musculoskeletal Tissue Engineering Study Section (MTE)
Program Officer
Belkin, Alexey
Project Start
2021-02-04
Project End
2025-11-30
Budget Start
2021-02-04
Budget End
2021-11-30
Support Year
1
Fiscal Year
2021
Total Cost
Indirect Cost
Name
University of Cincinnati
Department
Type
Schools of Pharmacy
DUNS #
041064767
City
Cincinnati
State
OH
Country
United States
Zip Code
45221